Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of reduced antibiotic treatment duration on antimicrobial resistance in critically ill patients in the randomized controlled SAPS-trial.
Shajiei A, Berends MS, Luz CF, van Oers JA, Harmsen HJM, Vos P, Klont R, Loef BG, Reidinga AC, Bormans-Russell L, Linsen K, Dormans T, Otten M, van der Bij A, Beishuizen A, de Lange DW, de Jong E, Nijsten MW. Shajiei A, et al. Among authors: van oers ja. Front Med (Lausanne). 2023 Feb 2;10:1080007. doi: 10.3389/fmed.2023.1080007. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36817782 Free PMC article.
[The role of allergy in interstitial cystitis].
Pelikan Z, van Oers JA, Levens WJ, Fouchier SM. Pelikan Z, et al. Among authors: van oers ja. Ned Tijdschr Geneeskd. 1999 Jun 19;143(25):1289-92. Ned Tijdschr Geneeskd. 1999. PMID: 10416480 Dutch.
Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E, de Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A. Assink-de Jong E, et al. Among authors: van oers ja. BMC Infect Dis. 2013 Apr 16;13:178. doi: 10.1186/1471-2334-13-178. BMC Infect Dis. 2013. PMID: 23590389 Free PMC article. Clinical Trial.
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW. de Jong E, et al. Among authors: van oers ja, van dam vc, van pelt j, van melsen gc, van den elsen mj, van de garde emw. Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2. Lancet Infect Dis. 2016. PMID: 26947523 Clinical Trial.
66 results